CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts ...

A new Covid variant, NB.1.8.1, is detected in US airports. The variant is driving a surge in cases across China. Cases are ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

The company said the submission for the vaccine, branded as Spikevax, is based on guidance from the FDA, which advised that the shots should be updated to target strains that are a part of JN.1 ...

Bartholomew County health officials said they are taking a wait-and-see approach after the Trump administration said it plans to limit approval for seasonal COVID-19 shots to seniors and others at ...

The FDA has declined to approve two more cancer therapies developed by drugmakers based in China, in what may be further evidence of a tough line taken by the regulator for drugs tested outside ...

The completion of the FDA filing prompts a $10 million milestone payment to Capricor from Japan's Nippon Shinyaku, which licensed US rights to deramiocel in 2022 and added in European rights in a ...